Single versus tandem autologous stem-cell transplantation in patients with newly diagnosed multiple myeloma and high-risk cytogenetics. A retrospective, open-label study of the PETHEMA/Spanish Myeloma Group (GEM)

被引：8

作者：

Villalba, Ana ^{[1
]}

Pilar Gonzalez-Rodriguez, Ana ^{[2
]}

Arzuaga-Mendez, Javier ^{[3
]}

Puig, Noemi ^{[4
]}

Arnao, Mario ^{[1
]}

Maria Arguinano, Jose ^{[5
]}

Jimenez, Maria ^{[6
]}

Canet, Marta ^{[7
]}

Teruel, Ana, I ^{[8
]}

Sola, Maria ^{[9
]}

Diaz, Francisco J. ^{[10
]}

Encinas, Cristina ^{[11
]}

Garcia, Antonio ^{[12
]}

Rosinol, Laura ^{[13
]}

Suarez, Alexia ^{[14
]}

Sonia Gonzalez, Marta ^{[15
]}

Izquierdo, Isabel ^{[16
]}

Teodoro Hernandez, Miguel ^{[17
]}

Stefania Infante, Maria ^{[18
]}

Jose Sanchez, Maria ^{[19
]}

Sampol, Antonia ^{[20
]}

de la Rubia, Javier ^{[1
,21
,22
]}

机构：

[1] Hosp Univ & Politecn La Fe, Hematol Dept, Valencia, Spain

[2] Hosp Univ Cent Asturias HUCA Oviedo, Hematol Dept, Oviedo, Spain

[3] Hosp Univ Cruces, Biocruces Bizkaia Hlth Res Inst, Hematol Dept, Grp Canc Hematol, Baracaldo, Spain

[4] Hosp Univ Salamanca HUSAL, Hematol Dept, CIBERONC, IBMCC USAL CSIC,IBSAL, Salamanca, Spain

[5] Complejo Hosp Navarra, Hematol Dept, Pamplona, Spain

[6] Hosp Univ Dr Peset, Hematol Dept, Valencia, Spain

[7] Hosp Univ Mutua Terrasa, Hematol Dept, Terrassa, Spain

[8] Hosp Clin Univ, Hematol Dept, Valencia, Spain

[9] Hosp Univ Morales Meseguer, Hematol Dept, Murcia, Spain

[10] Hosp Univ Burgos, Hematol Dept, Burgos, Spain

[11] Hosp Gen Univ Gregorio Maranon HGUGM, Hematol Dept, IiSGM, Madrid, Spain

[12] Hosp Arnau Vilanova, Hematol Dept, Lleida, Spain

[13] Hosp Clin Barcelona, Hematol Dept, Barcelona, Spain

[14] Hosp Gran Canaria Doctor Negrin, Hematol Dept, Las Palmas Gran Canaria, Municipality Of, Spain

[15] H Clin Univ Santiago Compostela, Hematol Dept, La Coruna, Spain

[16] Hosp Univ Miguel Servet, Hematol Dept, Zaragoza, Spain

[17] Hosp Univ Canarias, Hematol Dept, Santa Cruz De Tenerife, Spain

[18] Hosp Univ Infanta Leonor, Hematol Dept, Madrid, Spain

[19] Hosp Univ Lucus Augusti, Hematol Dept, Lugo, Spain

[20] Hosp Univ Son Espases, Hematol Dept, Palma De Mallorca, Spain

[21] Univ Catolica San Vicente Martir, Hematol Dept, Valencia, Spain

[22] CIBERONC CB16-12-00284, Valencia, Spain

来源：

LEUKEMIA & LYMPHOMA | 2022年 / 63卷 / 14期

关键词：

Multiple myeloma; autologous stem cell transplantation; high-risk cytogenetics; tandem transplantation; MINIMAL RESIDUAL DISEASE; DEXAMETHASONE; BORTEZOMIB; LENALIDOMIDE; SURVIVAL; CRITERIA; THERAPY; MAINTENANCE; MELPHALAN; CONSENSUS;

D O I：

10.1080/10428194.2022.2123229

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Tandem ASCT has been suggested as a valid approach to improve the prognosis of patients with MM and HR cytogenetic. In this observational, retrospective study, 213 patients with newly diagnosed MM and HR cytogenetic in 35 hospitals from the Spanish Myeloma Group underwent single or tandem ASCT between January 2015 and December 2019 after induction with VTD/VRD. HR cytogenetic was defined as having >= 1 of the following: del17p, t(4;14), t(14;16) or gain 1q21. More patients in the tandem group had R-ISS 3 and >1 cytogenetic abnormality at diagnosis. With a median follow-up of 31 months (range, 10-82), PFS after single ASCT was 41 months versus 48 months with tandem ASCT (p = 0.33). PFS in patients with del17p undergoing single ASCT was 41 months, while 52% of patients undergoing tandem ASCT were alive and disease free at 48 months. In conclusion, tandem ASCT partly overcomes the bad prognosis of HR cytogenetic.

引用

页码：3438 / 3447

页数：10

共 38 条

[1] Clinical characteristics and treatment outcomes of newly diagnosed multiple myeloma with chromosome 1q abnormalities [J].

Abdallah, Nadine ;

Greipp, Patricia ;

Kapoor, Prashant ;

Gertz, Morie A. ;

Dispenzieri, Angela ;

Baughn, Linda B. ;

Lacy, Martha Q. ;

Hayman, Suzanne R. ;

Buadi, Francis K. ;

Dingli, David ;

Go, Ronald S. ;

Hwa, Yi L. ;

Fonder, Amie ;

Hobbs, Miriam ;

Lin, Yi ;

Leung, Nelson ;

Kourelis, Taxiarchis ;

Warsame, Rahma ;

Siddiqui, Mustaqeem ;

Lust, John ;

Kyle, Robert A. ;

Bergsagel, Leif ;

Ketterling, Rhett ;

Rajkumar, S. Vincent ;

Kumar, Shaji K. .

BLOOD ADVANCES, 2020, 4 (15) :3509-3519

[2] Single versus double autologous stem-cell transplantation for multiple myeloma [J].

Attal, M ;

Harousseau, JL ;

Facon, T ;

Guilhot, F ;

Doyen, C ;

Fuzibet, JG ;

Monconduit, M ;

Hulin, C ;

Caillot, D ;

Bouabdallah, R ;

Voillat, L ;

Sotto, JJ ;

Grosbois, B ;

Bataille, R .

NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (26) :2495-2502

[3] Lenalidomide, Bortezomib, and Dexamethasone with Transplantation for Myeloma [J].

Attal, Michel ;

Lauwers-Cances, Valerie ;

Hulin, Cyrille ;

Leleu, Xavier ;

Caillot, Denis ;

Escoffre, Martine ;

Arnulf, Bertrand ;

Macro, Margaret ;

Belhadj, Karim ;

Garderet, Laurent ;

Roussel, Murielle ;

Payen, Catherine ;

Mathiot, Claire ;

Fermand, Jean P. ;

Meuleman, Nathalie ;

Rollet, Sandrine ;

Maglio, Michelle E. ;

Zeytoonjian, Andrea A. ;

Weller, Edie A. ;

Munshi, Nikhil ;

Anderson, Kenneth C. ;

Richardson, Paul G. ;

Facon, Thierry ;

Avet-Loiseau, Herve ;

Harousseau, Jean-Luc ;

Moreau, Philippe .

NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376 (14) :1311-1320

[4] Induction therapy prior to autologous stem cell transplantation (ASCT) in newly diagnosed multiple myeloma: an update [J].

Bazarbachi, Abdul Hamid ;

Al Hamed, Rama ;

Malard, Florent ;

Bazarbachi, Ali ;

Harousseau, Jean-Luc ;

Mohty, Mohamad .

BLOOD CANCER JOURNAL, 2022, 12 (03)

[5] Intravenous Busulfan and Melphalan as a Conditioning Regimen for Autologous Stem Cell Transplantation in Patients with Newly Diagnosed Multiple Myelotha: A Matched Comparison to a Melphalan-Only Approach [J].

Blanes, Margarita ;

Lahuerta, Juan J. ;

Gonzalez, Jose D. ;

Ribas, Paz ;

Solano, Carlos ;

Alegre, Adrian ;

Blade, Joan ;

San Miguel, Jesus F. ;

Sanz, Miguel A. ;

de la Rubia, Javier .

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2013, 19 (01) :69-74

[6] Response Improvement Rather than Response Status after First Autologous Stem Cell Transplantation Is a Significant Prognostic Factor for Survival Benefit from Tandem Compared with Single Transplantation in Multiple Myeloma Patients [J].

Blocka, Joanna ;

Hielscher, Thomas ;

Goldschmidt, Hartmut ;

Hillengass, Jens .

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2020, 26 (07) :1280-1287

[7] Autologous haematopoietic stem-cell transplantation versus bortezomib-melphalan-prednisone, with or without bortezomib-lenalidomide-dexamethasone consolidation therapy, and lenalidomide maintenance for newly diagnosed multiple myeloma (EMN02/HO95): a multicentre, randomised, open-label, phase 3 study [J].

Cavo, Michele ;

Gay, Francesca ;

Beksac, Meral ;

Pantani, Lucia ;

Petrucci, Maria Teresa ;

Dimopoulos, Meletios A. ;

Dozza, Luca ;

van der Holt, Bronno ;

Zweegman, Sonja ;

Oliva, Stefania ;

van der Velden, Vincent H. J. ;

Zamagni, Elena ;

Palumbo, Giuseppe A. ;

Patriarca, Francesca ;

Montefusco, Vittorio ;

Galli, Monica ;

Maisnar, Vladimir ;

Gamberi, Barbara ;

Hansson, Markus ;

Belotti, Angelo ;

Pour, Ludek ;

Ypma, Paula ;

Grasso, Mariella ;

Croockewit, Alexsandra ;

Ballanti, Stelvio ;

Offidani, Massimo ;

Vincelli, Iolanda D. ;

Zambello, Renato ;

Liberati, Anna Marina ;

Andersen, Niels Frost ;

Broijl, Annemiek ;

Troia, Rossella ;

Pascarella, Anna ;

Benevolo, Giulia ;

Levin, Mark-David ;

Bos, Gerard ;

Ludwig, Heinz ;

Aquino, Sara ;

Morelli, Anna Maria ;

Wu, Ka Lung ;

Boersma, Rinske ;

Hajek, Roman ;

Durian, Marc ;

Borne, Peter A. von dem ;

di Toritto, Tommaso Caravita ;

Zander, Thilo ;

Specchia, Giorgina ;

Waage, Anders ;

Gimsing, Peter ;

Mellqvist, Ulf-Henrik .

LANCET HAEMATOLOGY, 2020, 7 (06) :E456-E468

[8]

Cavo M, 2017, BLOOD, V130

[9] Double Vs Single Autologous Stem Cell Transplantation After Bortezomib-Based Induction Regimens For Multiple Myeloma: An Integrated Analysis Of Patient-Level Data From Phase European III Studies [J].

Cavo, Michele ;

Salwender, Hans ;

Rosinol, Laura ;

Moreau, Philippe ;

Petrucci, Maria Teresa ;

Blau, Igor Wolgang ;

Blade, Joan ;

Attal, Michel ;

Patriarca, Francesca ;

Weisel, Katja ;

San Miguel, Jesus F. ;

Avet-Loiseau, Herve ;

Testoni, Nicoletta ;

Pfreundschuh, Michael ;

Lahuerta, Juan Jose ;

Facon, Thierry ;

Pantani, Lucia ;

Scheid, Christof ;

Gutierrez, Norma ;

Marit, Gerald ;

Palumbo, Antonio ;

Martin, Maria Luisa ;

Caillot, Denis ;

Goldschmidt, Hartmut .

BLOOD, 2013, 122 (21)

[10] Impact of Post-Transplant Response and Minimal Residual Disease on Survival in Myeloma with High-Risk Cytogenetics [J].

Chakraborty, Rajshekhar ;

Muchtar, Eli ;

Kumar, Shaji K. ;

Jevremovic, Dragan ;

Buadi, Francis K. ;

Dingli, David ;

Dispenzieri, Angela ;

Hayman, Suzanne R. ;

Hogan, William J. ;

Kapoor, Prashant ;

Lacy, Martha Q. ;

Leung, Nelson ;

Gertz, Morie A. .

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2017, 23 (04) :598-605

← 1 2 3 4 →